Does Shanghai Lai Shi stock have long-term holding value?

Not worth it. In previous years, the fundamentals were not good, and the long-term holding was generally more than 5 years. It is not recommended to hold it.

Shanghai Lai Shi Company's annual reports from 20 14 to 20 17 try to draw a conclusion whether its stock is worth buying. Since 20 15, the stock market is not good, and the company has invested more stocks, and its income will fluctuate greatly. In 20 18, it announced its return to the main business, thus eliminating the impact of securities investment income, and the company mainly focused on the main business.

From the above figure, we can know that the main business of Shanghai Lai Shi is blood products, and its annual profit is still stable, but considering the continuous expansion and mergers and acquisitions of the company, such performance is not good enough.

Compared with the 20 17 annual report, the expanded data has not changed. Suppose its main business income can be restored to the level of 20 17 next year, with a profit of 692.52 million yuan. According to the P/E ratio of 30, its share price should be 4.2 yuan/share.

However, with the rise of the market index, its financial assets will increase in value, and the assets it has purchased in recent years will gradually play a role, and the proposed acquisition plan is also beneficial to the stock price. Under the influence of these three factors, the stock price has room for upward correction. As for the amount of correction, there are different opinions.